Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RIC-NEC Phase II Feasibility Randomized Controlled Trial: Remote Ischemic Conditioning in Necrotizing Enterocolitis

NCT05279664 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.

NCT NCT05279664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05279664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RIC-NEC Phase II Feasibility Randomized Controlled Trial: Remote Ischemic Conditioning in Necrotizing Enterocolitis
Lead sponsor
The Hospital for Sick Children
Phase
Phase 2
Overall status
Active, not recruiting
Start date
February 9, 2023
Completion date
March 18, 2026
Enrollment
78 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

necrotizing enterocolitis